year 3, Issue 9 (2-2004)                   J. Med. Plants 2004, 3(9): 23-34 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ziai S, Mahmoudian M, Keshavarz B, Poorhoseini L, Dastpak A, Ebrahimi A et al . Study of angiotensin converting enzyme (ACE) inhibitory effects of main Papaver spp. alkaloids. J. Med. Plants 2004; 3 (9) :23-34
1- Department of Pharmacology, Institute of Medicinal Plants, Tehran, Iran ,
2- Razi Institute For Drug Research, Iran University of Medical Sciences, Tehran, Iran
3- Azad University, Tehran, Iran
4- Department of Pharmacology, Institute of Medicinal Plants, Tehran, Iran
5- Department of Pharmacology, Iran University of Medical Sciences, Tehran, Iran
6- Analytical chemist, Tehran, Iran
Abstract:   (7395 Views)
Angiotensin converting enzyme (ACE) converts the inactive angiotensin I to (a potent vasoconstrictor and aldosterone releaser) angiotensin II. Inhibitors of ACE are valuable drugs in the treatment of hypertension, and heart failure. These inhibitors have a natural origin and non-peptide drugs were synthesized from the natural lead compounds. However, because of some side effects such as dry cough, many investigators are searching in natural products to find better and more selective lead compounds. There are reports on the interaction between rennin-angiotensin system and endogenous opioid system. Morphine and endogenous opioids have reported to inhibit ACE. In this research we examined the possible inhibitory effects of purified papaver’s main alkaloids on the activity of purified rabbit lung ACE. We found that only papaverin at 1 mM inhibited the enzyme by 40%. The Km value of ACE increased while Vmax decreased in papaverin treated samples. We conclude that part of hypotensive effects of papaverin may be related to ACE inhibition, and this compound will be a suitable lead compound for further investigation.
Full-Text [PDF 341 kb]   (11249 Downloads)    
Type of Study: Research | Subject: Pharmacognosy & Pharmaceutics
Received: 2002/06/7 | Accepted: 2004/01/30 | Published: 2004/03/9

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Medicinal Plants

Designed & Developed by : Yektaweb